Diagnosis and Treatment of Early GI Cancers (Esophageal, Gastric, and Colorectal Cancer)
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Causes, Screening and Diagnosis".
Deadline for manuscript submissions: closed (30 September 2021) | Viewed by 26606
Special Issue Editor
Interests: inflammation; malignant diseases; diagnosis; tumor biomarkers; specific proteins; neurodevelopmental disorders
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Gastrointestinal (GI) cancers are the group of cancers that affect the digestive system. These malignancies constitute the third most frequent cancers worldwide, while colorectal, gastric, and esophageal cancer are the most commonly diagnosed GI malignancies.
GI cancers are characterized by uncontrolled growth, rapid progression, and unfavorable prognosis. Curative surgery is regarded as the best option for cure, thus early detection of resectable GI cancers is sorely needed for better patient outcomes. Survival for patients with GI malignancies has been improving worldwide due to advances in diagnostic evaluation and multimodality treatments. Routine strategies involve a combination of imaging and biochemical diagnosis of cancer patients. However, there is still a need to find biomarkers that could help in the early diagnosis of GI cancer patients by providing a better understanding of the role of potential indicators in the pathogenesis of these malignancies.
The aim of this Special Issue is to provide new findings regarding biomarkers that could improve the diagnosis and treatment of GI cancer patients and to resume their potential clinical application in early detection. This Special Issue will highlight the current state-of-the-art in present and future prospects of biochemical and imaging detection, as well as legal aspects of the diagnosis and treatment of GI cancers (esophageal, gastric, and colorectal cancer).
Assoc. Prof. Marta Lukaszewicz-Zajac
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- gastrointestinal cancers
- tumor biomarkers
- biochemical diagnosis
- imaging diagnosis
- treatment
- tumor progression
- early cancers